Literature DB >> 15505315

Combined radiofrequency and alcohol injection for percutaneous hepatic tumor ablation.

Sridhar Shankar1, Eric vanSonnenberg, Paul R Morrison, Kemal Tuncali, Stuart G Silverman.   

Abstract

OBJECTIVE: We sought to determine if alcohol potentiates radiofrequency energy by obtaining larger ablative volumes in 30 liver tumors in human patients. SUBJECTS AND METHODS: We compared two groups of patients: one group treated with radiofrequency ablation alone (radiofrequency-alone group), and a second group treated with radiofrequency ablation and immediate prior injection of alcohol (combined group). The radiofrequency-alone group comprised 20 ablations (mean diameter, 8.4 cm; colorectal cancer metastases [n = 15]; other metastases [n = 5]). The combined group consisted of 30 radiofrequency ablations (mean diameter, 8.8 cm; metastatic colorectal cancer [n = 17]; other metastases [n = 8]; and hepatocellular carcinoma [n = 5]) treated with alcohol injection immediately before radiofrequency ablation. The amount of alcohol injected was determined by the size and location of tumors. Preprocedural laboratory tests (complete blood cell count with differential, liver function tests, and coagulation parameters) were performed in all patients, along with pre- and postprocedural CT, MRI, and PET. Measurements of tissue necrosis were obtained on the postprocedural CT scans and MR images. Volumes of necrosis calculated in each group were corrected for the number of radiofrequency applications and were statistically compared using the Student's t test. In addition, tissue impedances obtained during the radiofrequency ablation procedure were compared between the two groups.
RESULTS: The mean ablation volumes for the radiofrequency-alone group were 32.3 cm(2) (median, 28.6 cm(2); range, 14.4-61.8 cm(2)) and for the combined group, 84.6 cm(2) (median, 78.3 cm(2); range, 34.6-149 cm(2)). The difference in the necrosis volumes was significantly larger (p < 0.0001) in the combined group. Overall, the combined treatment group underwent fewer radiofrequency applications per session. Tissue impedance during radiofrequency ablation was higher in the combined group (mean, 62.7 vs 57.3 Omega in the radiofrequency alone group; p = 0.0005) at comparable times during the ablations. No major complications were seen in either group.
CONCLUSION: Percutaneous radiofrequency ablation appears to be potentiated by immediate prior alcohol injection into the tumor. Consistently larger lesions are obtainable in fewer sessions, without any increase of complications, using the combined method.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505315     DOI: 10.2214/ajr.183.5.1831425

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

1.  Ultrasound simulation of real-time temperature estimation during radiofrequency ablation using finite element models.

Authors:  M J Daniels; J Jiang; T Varghese
Journal:  Ultrasonics       Date:  2007-11-05       Impact factor: 2.890

2.  Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results.

Authors:  Miltiadis Krokidis; Stavros Spiliopoulos; Magdalena Jarzabek; Nikos Fotiadis; Tarun Sabharwal; Tim O'Brien; Andy Adam
Journal:  Eur Radiol       Date:  2013-03-09       Impact factor: 5.315

3.  Characteristics and pathological mechanism on magnetic resonance diffusion-weighted imaging after chemoembolization in rabbit liver VX-2 tumor model.

Authors:  You-Hong Yuan; En-Hua Xiao; Jian-Bin Liu; Zhong He; Ke Jin; Cong Ma; Jun Xiang; Jian-Hua Xiao; Wei-Jian Chen
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

4.  Characteristics of liver on magnetic resonance diffusion-weighted imaging: dynamic and image pathological investigation in rabbit liver VX-2 tumor model.

Authors:  You-Hong Yuan; En-Hua Xiao; Jian-Bin Liu; Zhong He; Ke Jin; Cong Ma; Jun Xiang; Jian-Hua Xiao; Wei-Jian Chen
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 5.  CT-guided radiofrequency ablation for lung cancer.

Authors:  Toshiyuki Matsuoka; Tomohisa Okuma
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

6.  Cryotherapy for liver metastases.

Authors:  Malgorzata M Bala; Robert P Riemsma; Robert Wolff; Michal Pedziwiatr; Jerzy W Mitus; Dawid Storman; Mateusz J Swierz; Jos Kleijnen
Journal:  Cochrane Database Syst Rev       Date:  2019-07-10

7.  Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma.

Authors:  Naveen Kalra; Mandeep Kang; Ajay K Duseja; Anmol Bhatia; Virendra Singh; Radha K Dhiman; Arvind Rajwanshi; Yogesh K Chawla; Niranjan Khandelwal
Journal:  Indian J Med Res       Date:  2017-11       Impact factor: 2.375

8.  Assessment of the feasibility of TACE combined with intratumoral injection of cisplatin in hepatocellular carcinoma.

Authors:  Song Zhaomin; Liu Zifeng; Yin Chenghui; Yang Jiali; Peng Xun; Zhao Peili; Lang Xiaolin
Journal:  Open Med (Wars)       Date:  2015-12-17

9.  Ultrasonic Cavitation Ameliorates Antitumor Efficacy of Residual Cancer After Incomplete Radiofrequency Ablation in Rabbit VX2 Liver Tumor Model.

Authors:  Shi-Yan Li; Pin-Tong Huang; Yong Fang; Yao Wu; Ling Zhou; Jie-Li Luo; Xian-Chen Wang; Yun-Chong Chen
Journal:  Transl Oncol       Date:  2019-06-05       Impact factor: 4.243

Review 10.  Advanced Techniques in the Percutaneous Ablation of Liver Tumours.

Authors:  Terrence Ch Hui; Justin Kwan; Uei Pua
Journal:  Diagnostics (Basel)       Date:  2021-03-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.